A current treatment approach for attention deficit hyperactivity disorder

Australian Prescriber

Volumn 31, Issue 5, 2008, Pages 129-132

  Vance, Alasdair ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atomoxetine; Dexamphetamine; Methylphenidate; Psychotropic drugs

Indexed keywords

ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLONIDINE; DEXAMPHETAMINE; IMIPRAMINE; METHAMPHETAMINE; METHYLPHENIDATE; PERICIAZINE; PSYCHOSTIMULANT AGENT; RISPERIDONE; SEDATIVE AGENT;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONDUCT DISORDER; DECREASED APPETITE; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG MECHANISM; DYSPHORIA; EMOTIONAL DISORDER; FUNCTIONAL DISEASE; GROWTH RETARDATION; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INSOMNIA; IRRITABILITY; LEARNING DISORDER; NAUSEA; NERVOUSNESS; PATIENT MONITORING; PSYCHOSOCIAL CARE; RASH; RISK FACTOR; SHORT SURVEY; SIDE EFFECT; SUICIDAL IDEATION; TIC; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION;

EID: 54249120520     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2008.072     Document Type: Short Survey

References (6)

1. Sandberg S. Hyperactivity and attention disorders of childhood. Cambridge: Cambridge University Press; 2002.
2. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 2004;13(Suppl 1):i7-i30.
3. Halasz G, Vance AL. Attention deficit hyperactivity disorder in children: moving forward with divergent perspectives. Med J Aust 2002;177:554-7.
4. Pliszka S; AACAP work group on quality issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921.
5. Vance A, Silk TJ, Casey M, Rinehart NJ, Bradshaw JL, Bellgrove MA, et al. Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study. Mol Psychiatry 2007;12:826-32.
6. Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. Circulation 2008;117:2407-23.